Vanguard Group Inc Edesa Biotech, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.63 - $0.99 $12 - $19	-20 Reduced 0.02%	110,862 $69,000
Q4 2022 Feb 10, 2023	BUY	$0.8 - $8.05 $135 - $1,360	169 Added 0.15%	110,882 $239,000
Q4 2021 Feb 14, 2022	SELL	$5.17 - $8.65 $2,678 - $4,480	-518 Reduced 0.47%	110,713 $623,000
Q3 2021 Nov 12, 2021	BUY	$4.2 - $11.92 $8,706 - $24,710	2,073 Added 1.9%	111,231 $821,000
Q2 2021 Aug 13, 2021	BUY	$4.93 - $6.69 $538,148 - $730,267	109,158 New	109,158 $576,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $38.2M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.